ClinConnect ClinConnect Logo
Search / Trial NCT06917339

Retrospective Analyses of TrakStar Database

Launched by NEURONETICS · Mar 31, 2025

Trial Information

Current as of June 14, 2025

Recruiting

Keywords

Tms

ClinConnect Summary

This clinical trial is looking at how different patient characteristics and treatment details affect the results of a specific therapy called NeuroStar TMS, which is used to help people with depression, obsessive-compulsive disorder (OCD), and anxiety-related depression. By examining real-world data from past patients, researchers hope to better understand what works best for different individuals. The study is currently recruiting participants aged between 18 and 43,829, and anyone can join, regardless of gender, as long as their treatment information is complete.

To be eligible for this trial, participants need to be male or female and have a valid age recorded in the database. They also need to have received treatment on or after November 1, 2008. Unfortunately, if there is missing information about a person’s treatment, they won’t be able to participate. If you join this study, you can expect to help researchers gather important insights that could improve future treatments for mental health conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female reported in database and not an invalid entry
  • Age reported and not an invalid entry
  • Treatment date of November 01, 2008 or later.
  • Exclusion Criteria:
  • • Incomplete information on treatment parameters

About Neuronetics

Neuronetics, a leading medical technology company, specializes in developing non-invasive solutions for neuropsychiatric disorders. With a focus on innovative therapies, Neuronetics is dedicated to advancing the field of neuromodulation through its flagship product, the NeuroStar® Advanced Therapy System, which utilizes Transcranial Magnetic Stimulation (TMS) to treat major depressive disorder. Committed to improving patient outcomes and enhancing the quality of life for individuals suffering from mental health conditions, Neuronetics actively engages in clinical trials to evaluate the efficacy and safety of its therapies, fostering a robust pipeline of research that underpins its mission to transform mental health treatment.

Locations

Malvern, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Eleanor Cole, PhD

Study Director

Neuronetics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported